课题基金 / 基金详情

Enhanced Ozone Disinfection of Biofilms in Waterlines

Enhanced Ozone Disinfection of Biofilms in Waterlines
水管中生物膜的强化臭氧消毒
批准号:
6643018
负责人:
Stuart Nemser
金额:
$38.93万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-01 至 2005-04-30

项目摘要

项目成果

Stuart Nemser的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dental Unit Waterlines have come under increasing scrutiny as residents of biofilms which harbor and release bacteria and in some instances harmful pathogens. As a result ADA has pro actively recommended that the water delivered by dental equipment have <200 colony forming units (CFU) of heterotrophic, mesophilic bacteria/ml of water. To date we have significantly exceeded our Phase 1 objectives. We demonstrated that within 5 minutes, moderate levels of dissolved O3 (>3 mg per liter) can remove all of the planktonic bacteria and reduce biofilm levels by 99.99%. This suggerts that routine treatment (e.g. 1 hour/day) with O3 will treat both free floating planktonic bacteria and biofilms. We have also shown through the use of a confocal laser scanning microscope that >50% of the microbial load in the biofilm can be inactivated within three minutes of treatment. We also demonstrated the supply of dissolved O3 in water without bubbles using composite CMS perfluoromembranes on chemically resistant micro porous supports. In parallel we have also established a commercial supply of CMS membrane devices for bubbleless O3 delivery and have demonstrated the performance of a commercial chemically inert CMS membrane device for ozone dissolution. Since we have the key components in place, commercialization of the O3 delivery system is simplified. Phase II will focus on expanding this technology towards the delivery of a functional prototype for clinical testing at a dental practice. We have brought on board 2 biofilm experts to evaluate biofilm removal and study potential for regrowth. Customization of the membrane device will be conducted during the Phase II study, prior to market introduction during Phase III.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Nanofiltration Membranes for Isolation of Pharmaceutical Compounds
  • 批准号:
    8122021
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2011
  • 负责人:
    Stuart Nemser
  • 依托单位:
Novel Nanofiltration Membranes for Isolation of Pharmaceutical Compounds
  • 批准号:
    8241947
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2011
  • 负责人:
    Stuart Nemser
  • 依托单位:
New Stable, High Flux Membrane for Osmotic Distillation of Labile Pharmaceutical
  • 批准号:
    7394247
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2008
  • 负责人:
    Stuart Nemser
  • 依托单位:
Novel Pharmaceutical Solvent - Water Separation System
  • 批准号:
    6880635
  • 项目类别:
  • 资助金额:
    $13.56万
  • 财政年份:
    2005
  • 负责人:
    Stuart Nemser
  • 依托单位:
国内基金
海外基金
靶向降解、清除幽门螺杆菌菌膜 (biofilm)的多功能脂质-聚合物杂化纳米粒的制备、作用评价及相关机制研究
  • 批准号:
    81473154
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2014
  • 负责人:
    胡海燕
  • 依托单位:
多物理场对大肠杆菌微生物膜(Biofilm)形成的影响
  • 批准号:
    11402265
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2014
  • 负责人:
    张榕京
  • 依托单位:
图们江流域农村生活污水处理中Atmosphere-Exposed Biofilm的净化机理及动力学研究
  • 批准号:
    51269032
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    49.0万元
  • 批准年份:
    2012
  • 负责人:
    金明姬
  • 依托单位:
铜绿假单胞菌氨肽酶对生物被膜(Biofilm)发育及抗性的贡献
  • 批准号:
    31140041
  • 项目类别:
    专项基金项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2011
  • 负责人:
    马旅雁
  • 依托单位: